What is Docusign's operating income?

Docusign's total operating income in 2026 was $298.58 million, based on the following breakdown: Total Gross Profit: $2.56 billion Total Operating Expenses: $2.26 billion

Docusign (DOCU) Financials

$45.03 +0.48 (+1.08%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$45.10 +0.07 (+0.16%)

As of 06/12/2026 07:59 PM Eastern

Compare

Annual Income Statements for Docusign

This table shows Docusign's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/31/2017	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025	1/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-115	-52	-426	-208	-243	-70	-97	74	1,068	309
Consolidated Net Income / (Loss)	-115	-52	-426	-208	-243	-70	-97	74	1,068	309
Net Income / (Loss) Continuing Operations	-115	-52	-426	-208	-243	-70	-97	74	1,068	309
Total Pre-Tax Income	-115	-49	-428	-204	-229	-67	-90	94	248	347
Total Operating Income	-116	-52	-426	-194	-174	-62	-88	32	200	299
Total Gross Profit	279	400	509	731	1,089	1,641	1,980	2,189	2,355	2,556
Total Revenue	381	519	701	974	1,453	2,107	2,516	2,762	2,977	3,220
Operating Revenue	381	519	701	974	1,453	2,107	2,516	2,762	2,977	3,220
Total Cost of Revenue	102	118	192	243	364	466	536	573	622	663
Operating Cost of Revenue	102	118	192	243	364	466	536	573	622	663
Total Operating Expenses	395	452	935	924	1,263	1,703	2,068	2,158	2,155	2,258
Selling, General & Admin Expense	64	82	209	147	193	233	316	420	376	389
Marketing Expense	241	278	540	591	799	1,077	1,243	1,168	1,161	1,204
Research & Development Expense	90	92	186	186	272	393	481	539	588	665
Restructuring Charge	-	-	-	-	0.00	0.00	28	30	30	0.00
Total Other Income / (Expense), net	0.76	2.51	-1.89	-10	-56	-5.03	-1.85	62	48	49
Interest Expense	0.61	0.62	11	29	65	6.44	6.39	6.84	1.55	2.55
Other Income / (Expense), net	1.37	3.14	8.96	19	8.91	1.41	4.54	69	50	51
Income Tax Expense	0.36	3.13	-1.75	4.80	14	3.06	7.57	20	-820	38
Basic Earnings per Share	($4.17)	($1.66)	($3.16)	($1.18)	($1.31)	($0.36)	($0.49)	$0.36	$5.23	$1.53
Weighted Average Basic Shares Outstanding	28.02M	32.29M	135.16M	176.70M	185.76M	196.68M	200.90M	204.07M	204.33M	202.08M
Diluted Earnings per Share	($4.17)	($1.66)	($3.16)	($1.18)	($1.31)	($0.36)	($0.49)	$0.36	$5.08	$1.48
Weighted Average Diluted Shares Outstanding	28.02M	32.29M	135.16M	176.70M	185.76M	196.68M	200.90M	208.95M	210.34M	209.12M
Weighted Average Basic & Diluted Shares Outstanding	28.02M	32.29M	135.16M	176.70M	185.76M	198.87M	201.90M	205.42M	202.49M	194.43M

This table shows Docusign's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026	Q1 2027
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
Net Income / (Loss) Attributable to Common Shareholders	39	27	34	888	62	83	72	63	84	90	78
Consolidated Net Income / (Loss)	39	27	34	888	62	83	72	63	84	90	78
Net Income / (Loss) Continuing Operations	39	27	34	888	62	83	72	63	84	90	78
Total Pre-Tax Income	36	30	37	72	72	68	74	76	96	102	118
Total Operating Income	20	9.94	23	58	59	60	60	65	85	88	111
Total Gross Profit	558	564	560	581	598	616	606	635	648	667	659
Total Revenue	700	712	710	736	755	776	764	801	818	837	830
Operating Revenue	700	712	710	736	755	776	764	801	818	837	830
Total Cost of Revenue	143	148	149	155	157	160	157	165	171	170	171
Operating Cost of Revenue	143	148	149	155	157	160	157	165	171	170	171
Total Operating Expenses	538	555	538	523	539	556	546	570	562	579	548
Selling, General & Admin Expense	108	103	92	87	98	99	90	95	98	106	92
Marketing Expense	292	300	282	287	291	301	296	305	297	306	296
Research & Development Expense	137	152	134	148	151	155	159	170	168	168	160
Total Other Income / (Expense), net	16	20	14	14	13	7.42	14	11	10	14	6.45
Interest Expense	1.58	1.71	0.14	0.54	0.46	0.40	0.48	0.83	0.65	0.59	0.55
Other Income / (Expense), net	18	22	14	15	13	7.82	14	12	11	14	7.00
Income Tax Expense	-2.97	2.50	2.83	-816	9.15	-16	1.70	13	12	11	40
Basic Earnings per Share	$0.19	$0.13	$0.16	$4.34	$0.31	$0.42	$0.35	$0.31	$0.41	$0.46	$0.40
Weighted Average Basic Shares Outstanding	204.46M	204.07M	205.87M	204.60M	203.57M	204.33M	203.28M	202.64M	201.95M	202.08M	195.49M
Diluted Earnings per Share	$0.19	$0.13	$0.16	$4.26	$0.30	$0.36	$0.34	$0.30	$0.40	$0.44	$0.40
Weighted Average Diluted Shares Outstanding	208.05M	208.95M	209.90M	208.27M	208.71M	210.34M	212.81M	210.96M	208.07M	209.12M	196.48M
Weighted Average Basic & Diluted Shares Outstanding	203.93M	205.42M	204.72M	202.97M	202.02M	202.49M	202.06M	201.10M	200.27M	194.43M	190.94M

This table details how cash moves in and out of Docusign's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/31/2017	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025	1/31/2026
Net Change in Cash & Equivalents	-38	62	265	-277	325	-57	214	78	-142	-41
Net Cash From Operating Activities	-4.79	55	76	116	297	506	507	980	1,017	1,165
Net Cash From Continuing Operating Activities	-4.79	55	76	116	297	506	505	980	1,017	1,160
Net Income / (Loss) Continuing Operations	-115	-52	-426	-208	-243	-70	-97	74	1,068	309
Consolidated Net Income / (Loss)	-115	-52	-426	-208	-243	-70	-97	74	1,068	309
Depreciation Expense	28	32	38	50	71	82	86	95	108	116
Amortization Expense	22	30	52	96	127	150	190	205	238	272
Non-Cash Adjustments To Reconcile Net Income	52	56	416	353	272	445	582	636	636	644
Changes in Operating Assets and Liabilities, net	7.54	-11	-3.08	-175	70	-100	-256	-31	-1,032	-181
Net Cash From Investing Activities	-41	-19	-664	-321	81	-163	-191	45	-313	-127
Net Cash From Continuing Investing Activities	-41	-19	-664	-321	81	-163	-191	45	-313	-127
Purchase of Property, Plant & Equipment	-43	-19	-30	-72	-82	-61	-78	-92	-97	-106
Acquisitions	0.00	0.00	0.00	0.00	-180	-6.39	0.00	0.00	-144	0.00
Purchase of Investments	0.00	-0.30	-634	-877	-174	-386	-537	-337	-413	-410
Sale and/or Maturity of Investments	1.79	0.00	0.00	627	518	291	424	474	340	390
Net Cash From Financing Activities	8.04	26	853	-70	-59	-395	-98	-946	-839	-1,100
Net Cash From Continuing Financing Activities	8.04	26	853	-70	-59	-395	-98	-946	-839	-1,100
Repayment of Debt	-	-0.39	-0.25	24	-387	-78	-0.02	-727	0.00	-3.13
Repurchase of Common Equity	0.00	-0.32	-4.01	-	0.00	0.00	-63	-146	-684	-869
Issuance of Common Equity	0.00	0.00	529	-	-	46	37	33	35	41
Other Financing Activities, net	8.04	26	-233	-94	-380	-363	-72	-107	-191	-268
Effect of Exchange Rate Changes	-	-	-	-	5.65	-5.59	-3.78	0.20	-7.55	20
Cash Interest Paid	0.60	0.60	0.20	2.85	78	0.35	0.19	0.19	0.00	0.00
Cash Income Taxes Paid	0.23	0.62	3.21	1.97	3.50	6.94	10	10	24	13

This table details how cash moves in and out of Docusign's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026	Q1 2027
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
Net Change in Cash & Equivalents	171	-392	21	-195	-7.27	39	13	-56	-16	18	-52
Net Cash From Operating Activities	264	271	255	220	234	308	251	246	290	377	322
Net Cash From Continuing Operating Activities	268	271	253	220	234	308	251	246	290	373	322
Net Income / (Loss) Continuing Operations	39	27	34	888	62	83	72	63	84	90	78
Consolidated Net Income / (Loss)	39	27	34	888	62	83	72	63	84	90	78
Depreciation Expense	23	24	25	27	28	29	30	29	30	26	32
Amortization Expense	51	53	54	57	61	65	66	69	69	68	67
Non-Cash Adjustments To Reconcile Net Income	164	165	149	173	159	154	152	165	166	161	148
Changes in Operating Assets and Liabilities, net	-8.77	1.14	-8.12	-926	-76	-23	-70	-80	-58	27	-4.24
Net Cash From Investing Activities	34	67	-61	-176	-44	-32	-25	-30	-38	-34	-39
Net Cash From Continuing Investing Activities	34	67	-61	-176	-44	-32	-25	-30	-38	-34	-39
Purchase of Property, Plant & Equipment	-24	-22	-23	-22	-24	-28	-24	-28	-27	-27	-32
Purchase of Investments	-29	-133	-120	-104	-110	-78	-93	-120	-110	-88	-100
Sale and/or Maturity of Investments	88	222	82	94	90	75	91	118	99	82	93
Net Cash From Financing Activities	-121	-735	-170	-239	-198	-232	-224	-273	-270	-333	-334
Net Cash From Continuing Financing Activities	-121	-735	-170	-239	-198	-232	-224	-273	-270	-333	-334
Repayment of Debt	-	-690	-	-	-	-	0.00	-	-	-	-0.22
Repurchase of Common Equity	-75	-	-149	-200	-173	-162	-183	-202	-215	-269	-318
Issuance of Common Equity	15	-	20	-	15	-	22	-	19	-	23
Other Financing Activities, net	-23	-45	-41	-39	-41	-70	-62	-69	-74	-64	-39
Effect of Exchange Rate Changes	-7.19	5.10	-2.92	0.24	0.44	-5.31	9.92	1.53	1.92	6.90	-0.48

This table presents Docusign's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025	1/31/2026
Total Assets	620	1,615	1,891	2,337	2,541	3,013	2,971	4,013	4,230
Total Current Assets	419	985	944	1,162	1,320	1,631	1,568	1,489	1,491
Cash & Equivalents	257	518	241	566	509	722	797	649	602
Accounts Receivable	124	175	238	324	441	517	439	430	516
Prepaid Expenses	23	30	37	48	63	70	67	82	97
Other Current Assets	14	11	13	17	13	322	264	329	275
Plant, Property, & Equipment, net	63	76	128	165	185	200	245	299	362
Total Noncurrent Assets	138	555	819	1,009	1,037	1,182	1,158	2,224	2,377
Goodwill	37	195	195	350	355	354	353	454	458
Intangible Assets	14	74	57	122	99	70	51	76	61
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	2.03	840	835
Other Noncurrent Operating Assets	87	121	328	444	488	758	752	853	1,022
Total Liabilities & Shareholders' Equity	620	1,615	1,891	2,337	2,541	3,013	2,971	4,013	4,230
Total Liabilities	411	1,001	1,345	2,007	2,266	2,395	1,842	2,010	2,312
Total Current Liabilities	374	516	694	1,093	1,372	2,208	1,661	1,832	2,039
Accounts Payable	24	20	28	37	53	24	19	31	17
Accrued Expenses	16	36	54	67	91	101	104	100	113
Current Employee Benefit Liabilities	51	78	83	156	160	163	195	227	261
Other Current Liabilities	282	381	528	813	37	1,197	1,342	1,475	1,648
Total Noncurrent Liabilities	37	485	651	914	894	187	181	178	272
Noncurrent Deferred & Payable Income Tax Liabilities	2.51	4.21	4.92	6.46	9.32	11	17	21	22
Other Noncurrent Operating Liabilities	12	17	181	215	150	176	164	158	251
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-339	614	546	326	276	617	1,130	2,003	1,918
Total Preferred & Common Equity	-339	614	546	326	276	617	1,130	2,003	1,918
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-339	614	546	326	276	617	1,130	2,003	1,918
Common Stock	160	1,545	1,685	1,702	1,720	2,241	2,821	3,321	3,778
Retained Earnings	-502	-929	-1,137	-1,380	-1,438	-1,599	-1,670	-1,287	-1,856
Accumulated Other Comprehensive Income / (Loss)	3.40	-1.97	-1.67	4.96	-4.81	-23	-19	-28	-3.71

This table presents Docusign's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026	Q1 2027
Period end date	10/31/2022	4/30/2023	7/31/2023	10/31/2023	4/30/2024	7/31/2024	10/31/2024	4/30/2025	7/31/2025	10/31/2025	4/30/2026
Total Assets	2,732	3,130	3,267	3,338	2,927	3,754	3,770	3,947	3,950	3,982	3,984
Total Current Assets	1,480	1,804	1,956	2,043	1,490	1,343	1,332	1,377	1,319	1,307	1,256
Cash & Equivalents	633	940	1,018	1,189	817	619	611	657	600	583	548
Accounts Receivable	423	409	415	360	306	310	300	308	357	355	301
Prepaid Expenses	69	87	81	73	85	82	75	111	108	103	133
Other Current Assets	356	368	442	421	282	333	345	301	254	266	274
Plant, Property, & Equipment, net	196	206	221	231	256	266	279	310	328	344	388
Total Noncurrent Assets	1,055	1,120	1,090	1,064	1,181	2,145	2,160	2,260	2,303	2,331	2,340
Goodwill	352	353	353	351	352	456	456	455	456	457	459
Intangible Assets	75	65	60	56	46	90	83	69	65	61	57
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	822	817	845	837	839	805
Other Noncurrent Operating Assets	627	701	676	657	782	777	804	891	945	974	1,020
Total Liabilities & Shareholders' Equity	2,732	3,130	3,267	3,338	2,927	3,754	3,770	3,947	3,950	3,982	3,984
Total Liabilities	2,263	2,380	2,420	2,373	1,790	1,793	1,781	1,933	1,962	2,001	2,164
Total Current Liabilities	1,450	2,195	2,234	2,189	1,605	1,607	1,599	1,741	1,776	1,784	1,889
Accounts Payable	47	15	5.80	15	18	8.12	18	25	11	22	24
Accrued Expenses	96	102	109	100	99	93	95	101	101	120	108
Current Employee Benefit Liabilities	146	142	162	159	154	179	159	171	208	181	176
Other Current Liabilities	1,123	1,213	1,231	1,226	1,334	1,327	1,327	1,445	1,457	1,460	1,581
Total Noncurrent Liabilities	814	185	186	183	185	185	182	191	186	217	276
Noncurrent Deferred & Payable Income Tax Liabilities	10	12	14	17	18	18	19	22	19	18	24
Other Noncurrent Operating Liabilities	118	173	172	166	167	167	163	169	166	198	252
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	469	749	848	965	1,137	1,961	1,989	2,015	1,988	1,982	1,820
Total Preferred & Common Equity	469	749	848	965	1,137	1,961	1,989	2,015	1,988	1,982	1,820
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	469	749	848	965	1,137	1,961	1,989	2,015	1,988	1,982	1,820
Common Stock	2,108	2,412	2,531	2,693	2,950	3,088	3,226	3,435	3,544	3,666	3,921
Retained Earnings	-1,604	-1,639	-1,661	-1,697	-1,786	-1,099	-1,210	-1,399	-1,537	-1,669	-2,097
Accumulated Other Comprehensive Income / (Loss)	-34	-22	-20	-28	-25	-25	-24	-18	-16	-12	-3.96

This table displays calculated financial ratios and metrics derived from Docusign's official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/31/2017	1/31/2018	1/31/2019	1/31/2020	1/31/2021	1/31/2022	1/31/2023	1/31/2024	1/31/2025	1/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	200,272,740.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	200,272,740.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	1.54
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	-81	-36	-298	-135	-122	-43	-62	25	861	266
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-4.60%	2.21%	43.00%	13.85%
Earnings before Interest and Taxes (EBIT)	-114	-49	-417	-174	-165	-60	-83	101	249	350
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-64	14	-328	-28	34	171	193	400	595	738
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	12	-467	-132	-183	37	-584	311	-160	304
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	-49	120	116	177	96	618	333	1,354	1,315
Increase / (Decrease) in Invested Capital	0.00	-49	168	-3.92	61	-80	522	-286	1,021	-39
Book Value per Share	$0.00	($10.49)	$3.72	$3.04	$1.75	$1.39	$3.07	$5.54	$9.91	$9.58
Tangible Book Value per Share	$0.00	($12.08)	$2.09	$1.64	($0.78)	($0.90)	$0.96	$3.56	$7.29	$6.98
Total Capital	0.00	209	1,053	1,012	1,043	994	1,340	1,130	2,003	1,918
Total Debt	0.00	0.00	439	465	714	718	723	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	439	465	693	718	0.00	0.00	0.00	0.00
Net Debt	0.00	-257	-495	-431	-153	-179	0.99	-797	-649	-602
Capital Expenditures (CapEx)	43	19	30	72	82	61	78	92	97	106
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-212	-301	-406	-684	-855	-576	-890	-991	-1,151
Debt-free Net Working Capital (DFNWC)	0.00	45	468	250	90	-52	146	-93	-343	-549
Net Working Capital (NWC)	0.00	45	468	250	69	-52	-577	-93	-343	-549
Net Nonoperating Expense (NNE)	34	16	128	73	122	27	36	-49	-207	-43
Net Nonoperating Obligations (NNO)	0.00	-257	-495	-431	-153	-179	0.99	-797	-649	-602
Total Depreciation and Amortization (D&A)	51	62	90	146	198	231	276	300	346	388
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($4.17)	($1.66)	($3.16)	($1.18)	($1.31)	($0.36)	($0.49)	$0.36	$5.23	$1.53
Adjusted Weighted Average Basic Shares Outstanding	28.02M	32.29M	169.90M	362.91M	193.09M	196.68M	200.90M	204.07M	204.33M	202.08M
Adjusted Diluted Earnings per Share	($4.17)	($1.66)	($3.16)	($1.18)	($1.31)	($0.36)	($0.49)	$0.36	$5.08	$1.48
Adjusted Weighted Average Diluted Shares Outstanding	28.02M	32.29M	169.90M	362.91M	193.09M	196.68M	200.90M	208.95M	210.34M	209.12M
Adjusted Basic & Diluted Earnings per Share	($4.17)	($1.66)	($3.16)	($1.18)	($1.31)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	28.02M	32.29M	135.16M	176.70M	185.76M	198.87M	201.90M	205.42M	202.49M	194.43M
Normalized Net Operating Profit after Tax (NOPAT)	-81	-36	-298	-135	-122	-43	-42	49	161	266
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Docusign's official financial filings.

Metric	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026	Q1 2027
Period end date	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026	4/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	200,272,740.00	194,427,928.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	200,272,740.00	194,427,928.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.45	0.40
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.51%	8.01%	7.30%	7.03%	7.77%	8.97%	7.61%	8.78%	8.42%	-	8.72%
EBITDA Growth	171.81%	33.50%	44.61%	55.75%	44.58%	48.97%	48.16%	11.65%	21.19%	-	27.32%
EBIT Growth	240.58%	344.10%	383.76%	200.96%	92.55%	117.12%	102.16%	6.71%	33.52%	-	59.30%
NOPAT Growth	211.32%	3,677.65%	4,786.73%	32,726.90%	140.86%	717.27%	181.97%	-92.48%	45.31%	-	25.57%
Net Income Growth	229.93%	460.17%	6,163.45%	11,910.97%	60.86%	206.49%	113.53%	-92.91%	34.13%	-	8.48%
EPS Growth	226.67%	550.00%	0.00%	10,550.00%	57.89%	176.92%	112.50%	-92.96%	33.33%	-	17.65%
Operating Cash Flow Growth	402.84%	97.51%	9.07%	4.36%	-11.30%	13.75%	-1.33%	11.75%	23.88%	-	27.94%
Free Cash Flow Firm Growth	122.04%	156.42%	144.43%	86.79%	-859.15%	-421.35%	-517.89%	111.04%	106.39%	-	116.30%
Invested Capital Growth	-16.52%	-46.19%	-40.03%	141.83%	196.09%	307.02%	324.70%	3.40%	1.43%	-	-6.31%
Revenue Q/Q Growth	1.85%	1.71%	-0.39%	3.72%	2.55%	2.84%	-1.62%	4.84%	2.21%	-	-0.79%
EBITDA Q/Q Growth	10.58%	-2.58%	6.54%	35.69%	2.65%	0.38%	5.96%	2.26%	11.42%	-	10.99%
EBIT Q/Q Growth	55.45%	-15.93%	16.81%	97.16%	-0.55%	-5.20%	8.76%	4.07%	24.45%	-	15.83%
NOPAT Q/Q Growth	882.48%	-57.43%	129.42%	3,320.98%	-92.79%	44.45%	-20.85%	-8.74%	39.26%	-	-5.27%
Net Income Q/Q Growth	424.75%	-29.80%	23.93%	2,530.96%	-92.97%	33.75%	-13.66%	-12.65%	32.96%	-	-13.41%
EPS Q/Q Growth	375.00%	-31.58%	23.08%	2,562.50%	-92.96%	20.00%	-5.56%	-11.76%	33.33%	-	-9.09%
Operating Cash Flow Q/Q Growth	25.19%	2.47%	-5.86%	-13.59%	6.41%	31.40%	-18.34%	-2.13%	17.96%	-	-14.72%
Free Cash Flow Firm Q/Q Growth	120.52%	159.70%	-20.51%	-131.20%	-1,078.68%	-9.93%	-3.37%	100.82%	582.43%	-	36.74%
Invested Capital Q/Q Growth	-16.13%	-28.54%	-3.93%	319.99%	2.69%	-1.77%	0.25%	2.25%	0.74%	-	-3.32%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	79.63%	79.24%	78.94%	78.88%	79.26%	79.36%	79.41%	79.33%	79.16%	-	79.37%
EBITDA Margin	15.90%	15.23%	16.29%	21.31%	21.33%	20.82%	22.43%	21.87%	23.84%	-	26.24%
Operating Margin	2.82%	1.39%	3.19%	7.85%	7.82%	7.79%	7.89%	8.15%	10.43%	-	13.41%
EBIT Margin	5.34%	4.41%	5.18%	9.84%	9.54%	8.80%	9.73%	9.65%	11.75%	-	14.25%
Profit (Net Income) Margin	5.54%	3.82%	4.76%	120.68%	8.27%	10.76%	9.44%	7.87%	10.23%	-	9.42%
Tax Burden Percent	108.29%	91.59%	92.26%	1,235.57%	87.21%	122.99%	97.69%	82.36%	87.64%	-	66.41%
Interest Burden Percent	95.78%	94.57%	99.61%	99.25%	99.36%	99.41%	99.36%	98.93%	99.32%	-	99.53%
Effective Tax Rate	-8.29%	8.41%	7.74%	-1,135.57%	12.79%	-22.99%	2.31%	17.64%	12.36%	-	33.59%
Return on Invested Capital (ROIC)	16.16%	7.42%	19.39%	292.35%	21.55%	33.81%	27.86%	15.21%	20.80%	-	22.26%
ROIC Less NNEP Spread (ROIC-NNEP)	7.66%	2.86%	16.90%	254.17%	19.58%	32.55%	26.07%	13.70%	19.31%	-	21.55%
Return on Net Nonoperating Assets (RNNOA)	-2.19%	-1.30%	-9.26%	-82.49%	-7.36%	-15.02%	-12.20%	-4.23%	-5.81%	-	-6.77%
Return on Equity (ROE)	13.97%	6.12%	10.13%	209.86%	14.19%	18.79%	15.66%	10.99%	14.99%	-	15.48%
Cash Return on Invested Capital (CROIC)	21.12%	65.32%	61.94%	-17.10%	-20.88%	-19.01%	-13.86%	14.06%	17.41%	-	27.94%
Operating Return on Assets (OROA)	4.77%	4.08%	4.80%	8.01%	7.82%	7.50%	8.58%	7.76%	9.58%	-	11.81%
Return on Assets (ROA)	4.95%	3.53%	4.41%	98.26%	6.78%	9.17%	8.32%	6.32%	8.34%	-	7.80%
Return on Common Equity (ROCE)	13.97%	6.12%	10.13%	209.86%	14.19%	18.79%	15.66%	10.99%	14.99%	-	15.48%
Return on Equity Simple (ROE_SIMPLE)	5.35%	0.00%	9.43%	50.37%	50.85%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	21	9.10	21	714	51	74	59	54	75	78	74
NOPAT Margin	3.05%	1.28%	2.94%	97.03%	6.82%	9.58%	7.71%	6.71%	9.14%	-	8.90%
Net Nonoperating Expense Percent (NNEP)	8.50%	4.56%	2.49%	38.18%	1.97%	1.26%	1.79%	1.52%	1.49%	-	0.71%
Return On Investment Capital (ROIC_SIMPLE)	-	0.81%	-	-	-	3.71%	2.92%	2.70%	3.78%	4.07%	4.06%
Cost of Revenue to Revenue	20.37%	20.76%	21.06%	21.12%	20.74%	20.64%	20.59%	20.67%	20.84%	-	20.63%
SG&A Expenses to Revenue	15.45%	14.42%	13.03%	11.84%	12.92%	12.73%	11.82%	11.85%	12.01%	-	11.07%
R&D to Revenue	19.51%	21.27%	18.93%	20.05%	20.02%	20.03%	20.88%	21.19%	20.48%	-	19.22%
Operating Expenses to Revenue	76.82%	77.84%	75.75%	71.02%	71.44%	71.57%	71.52%	71.19%	68.73%	-	65.96%
Earnings before Interest and Taxes (EBIT)	37	31	37	72	72	68	74	77	96	102	118
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	111	108	116	157	161	162	171	175	195	196	218
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.19	11.00	10.23	5.79	7.08	9.76	8.22	7.69	7.42	-	4.91
Price to Tangible Book Value (P/TBV)	14.16	17.12	15.75	8.02	9.71	13.28	11.11	10.42	10.05	-	6.86
Price to Revenue (P/Rev)	2.92	4.50	4.14	3.97	4.83	6.56	5.46	4.94	4.66	-	2.72
Price to Earnings (P/E)	153.11	167.93	108.46	11.50	13.92	18.30	14.96	54.40	48.66	-	28.37
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Earnings Yield	0.65%	0.60%	0.92%	8.70%	7.18%	5.46%	6.68%	1.84%	2.06%	-	3.53%
Enterprise Value to Invested Capital (EV/IC)	15.90	34.95	33.82	8.00	9.77	13.95	11.71	10.58	10.10	-	6.60
Enterprise Value to Revenue (EV/Rev)	2.73	4.21	3.85	3.76	4.62	6.35	5.24	4.74	4.47	-	2.55
Enterprise Value to EBITDA (EV/EBITDA)	19.83	29.03	24.78	21.81	24.86	31.75	24.43	21.95	20.09	-	10.70
Enterprise Value to EBIT (EV/EBIT)	97.19	115.66	83.36	60.32	63.35	75.73	55.38	50.31	44.70	-	21.31
Enterprise Value to NOPAT (EV/NOPAT)	464.59	465.40	213.33	17.18	18.70	21.94	17.25	61.80	54.03	-	29.80
Enterprise Value to Operating Cash Flow (EV/OCF)	8.75	11.87	10.80	10.63	13.75	18.57	15.68	14.12	12.89	-	6.80
Enterprise Value to Free Cash Flow (EV/FCFF)	68.51	37.43	40.94	0.00	0.00	0.00	0.00	76.50	58.44	-	22.85
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Financial Leverage	-0.29	-0.46	-0.55	-0.32	-0.38	-0.46	-0.47	-0.31	-0.30	-	-0.31
Leverage Ratio	4.23	3.43	3.21	2.50	2.41	2.23	2.18	1.95	1.95	-	2.07
Compound Leverage Factor	4.06	3.24	3.20	2.48	2.39	2.22	2.17	1.93	1.94	-	2.06
Debt to Total Capital	41.66%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Short-Term Debt to Total Capital	41.66%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Common Equity to Total Capital	58.34%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	100.00%
Debt to EBITDA	1.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Net Debt to EBITDA	-1.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Debt to NOPAT	43.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Net Debt to NOPAT	-31.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Altman Z-Score	2.08	4.19	4.00	4.13	5.05	6.08	5.36	4.84	4.55	-	2.47
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.93	0.94	0.93	0.84	0.83	0.81	0.79	0.74	0.73	-	0.66
Quick Ratio	0.71	0.74	0.70	0.58	0.57	0.59	0.55	0.54	0.53	-	0.45
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	113	295	234	-73	-861	-947	-979	8.07	55	117	160
Operating Cash Flow to CapEx	1,108.08%	1,224.10%	1,119.97%	988.37%	992.36%	1,086.42%	1,064.34%	865.69%	1,060.40%	-	997.39%
Free Cash Flow to Firm to Interest Expense	71.96	172.44	1,626.79	-134.35	-1,864.63	-2,367.56	-2,047.96	9.75	84.23	-	289.65
Operating Cash Flow to Interest Expense	167.52	158.40	1,769.63	404.79	507.20	769.78	526.02	297.19	443.84	-	583.83
Operating Cash Flow Less CapEx to Interest Expense	152.40	145.46	1,611.62	363.84	456.09	698.93	476.60	262.86	401.99	-	525.29
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.89	0.92	0.93	0.81	0.82	0.85	0.88	0.80	0.82	-	0.83
Accounts Receivable Turnover	6.92	5.78	7.86	7.89	8.81	6.85	9.88	9.28	9.64	-	10.80
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Fixed Asset Turnover	12.69	12.41	12.17	11.75	11.43	10.93	10.71	10.43	10.15	-	9.41
Accounts Payable Turnover	18.14	26.37	36.16	85.56	37.01	25.00	29.77	68.18	32.17	-	27.89
Days Sales Outstanding (DSO)	52.75	63.18	46.42	46.26	41.41	53.27	36.96	39.32	37.87	-	33.78
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Days Payable Outstanding (DPO)	20.12	13.84	10.09	4.27	9.86	14.60	12.26	5.35	11.35	-	13.09
Cash Conversion Cycle (CCC)	32.64	49.35	36.33	42.00	31.54	38.67	24.70	33.96	26.52	-	20.70
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	466	333	320	1,342	1,379	1,354	1,357	1,388	1,398	1,315	1,272
Invested Capital Turnover	5.30	5.81	6.59	3.01	3.16	3.53	3.61	2.27	2.28	-	2.50
Increase / (Decrease) in Invested Capital	-92	-286	-213	787	913	1,021	1,038	46	20	-39	-86
Enterprise Value (EV)	7,401	11,627	10,809	10,739	13,471	18,893	15,896	14,684	14,125	-	8,394
Market Capitalization	7,901	12,424	11,626	11,358	14,082	19,542	16,554	15,284	14,709	-	8,942
Book Value per Share	$4.75	$5.54	$5.54	$9.58	$9.80	$9.91	$9.95	$9.84	$9.85	$9.58	$9.36
Tangible Book Value per Share	$2.75	$3.56	$3.59	$6.92	$7.15	$7.29	$7.36	$7.26	$7.28	$6.98	$6.71
Total Capital	1,654	1,130	1,137	1,961	1,989	2,003	2,015	1,988	1,982	1,918	1,820
Total Debt	689	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-499	-797	-817	-619	-611	-649	-657	-600	-583	-602	-548
Capital Expenditures (CapEx)	24	22	23	22	24	28	24	28	27	27	32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-646	-890	-933	-883	-878	-991	-1,022	-1,057	-1,060	-1,151	-1,181
Debt-free Net Working Capital (DFNWC)	543	-93	-115	-264	-267	-343	-364	-457	-477	-549	-633
Net Working Capital (NWC)	-147	-93	-115	-264	-267	-343	-364	-457	-477	-549	-633
Net Nonoperating Expense (NNE)	-17	-18	-13	-174	-11	-9.12	-13	-9.25	-8.92	-12	-4.28
Net Nonoperating Obligations (NNO)	-499	-797	-817	-619	-611	-649	-657	-600	-583	-602	-548
Total Depreciation and Amortization (D&A)	74	77	79	84	89	93	97	98	99	94	100
Debt-free, Cash-free Net Working Capital to Revenue	-23.85%	-32.22%	-33.19%	-30.89%	-30.13%	-33.30%	-33.71%	-34.16%	-33.55%	-	-35.94%
Debt-free Net Working Capital to Revenue	20.03%	-3.37%	-4.10%	-9.23%	-9.16%	-11.51%	-12.02%	-14.78%	-15.09%	-	-19.26%
Net Working Capital to Revenue	-5.41%	-3.37%	-4.10%	-9.23%	-9.16%	-11.51%	-12.02%	-14.78%	-15.09%	-	-19.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.19	$0.13	$0.16	$4.34	$0.31	$0.42	$0.35	$0.31	$0.41	$0.46	$0.40
Adjusted Weighted Average Basic Shares Outstanding	204.46M	204.07M	205.87M	204.60M	203.57M	204.33M	203.28M	202.64M	201.95M	202.08M	195.49M
Adjusted Diluted Earnings per Share	$0.19	$0.13	$0.16	$4.26	$0.30	$0.36	$0.34	$0.30	$0.40	$0.44	$0.40
Adjusted Weighted Average Diluted Shares Outstanding	208.05M	208.95M	209.90M	208.27M	208.71M	210.34M	212.81M	210.96M	208.07M	209.12M	196.48M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	203.93M	205.42M	204.72M	202.97M	202.02M	202.49M	202.06M	201.10M	200.27M	194.43M	190.94M
Normalized Net Operating Profit after Tax (NOPAT)	14	9.18	48	41	51	42	59	54	75	78	74
Normalized NOPAT Margin	2.04%	1.29%	6.73%	5.55%	6.82%	5.45%	7.71%	6.71%	9.14%	-	8.90%
Pre Tax Income Margin	5.12%	4.18%	5.16%	9.77%	9.48%	8.75%	9.66%	9.55%	11.67%	-	14.18%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	23.72	18.40	255.12	133.15	155.92	170.72	155.37	93.34	147.07	-	214.71
NOPAT to Interest Expense	13.55	5.32	144.97	1,312.81	111.43	185.92	123.15	64.88	114.39	-	134.15
EBIT Less CapEx to Interest Expense	8.60	5.46	97.11	92.19	104.81	99.86	105.95	59.01	105.21	-	156.18
NOPAT Less CapEx to Interest Expense	-1.56	-7.62	-13.03	1,271.86	60.32	115.06	73.72	30.55	72.53	-	75.61
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Augmented Payout Ratio	281.99%	196.70%	237.04%	42.93%	51.58%	64.01%	64.90%	256.02%	252.00%	-	318.27%

Financials Breakdown Chart

Key Financial Trends

Here are the four-year trends for DOCUSIGN (NASDAQ: DOCU) based on the quarterly income statements, cash flow statements, and balance sheets from 2023 through 2026. The focus is on meaningful shifts for retail investors evaluating profitability, cash generation, and capital allocation.

Revenue growth persists: Revenue has trended higher over the period, rising from about $659.6M in 2023 Q4 to $836.9M in 2026 Q4, continuing a multi-year growth trajectory.
Gross margin remains robust: 2026 Q4 gross profit was $667.1M on $836.9M revenue, a gross margin near 79.7%, indicating solid pricing power and cost of goods management.
Net income and earnings per share improve: Latest quarter (2026 Q4) shows net income attributable to common shareholders of about $90.3M with diluted EPS of $0.44 and basic EPS of $0.46, signaling improved profitability versus earlier periods.
Operating cash flow stays positive and growing: Net cash from continuing operating activities was about $372.5M in 2026 Q4 (and total operating cash flow near $377.2M), underscoring strong cash generation from core operations. Free cash flow remains positive after capex.
Capital allocation dynamics: The company continued share repurchases in 2026, signaling confidence in the business and a focus on per-share metrics, though this contributes to financing outflows.
R&D and S&M expenses remain meaningful: R&D and marketing/SG&A run at high absolute levels and represent a meaningful portion of revenue, consistent with a growth-focused spend profile.
Working capital remains tight at times: In several 2026 quarters, current liabilities exceed current assets (e.g., about $1.78B current liabilities vs. ~$1.31B current assets in 2026 Q3), implying a tighter short-term liquidity profile despite healthy cash flow.
Heavy financing outflows from buybacks: Stock repurchases and other financing activities represent a substantial cash outflow in many quarters (2026 periods show notable repurchases), contributing to negative net financing cash flow despite positive operating cash flow.

06/13/26 05:29 AM ETAI Generated. May Contain Errors.

Docusign Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Docusign's financial year ends in January. Their financial year 2026 ended on January 31, 2026.

Docusign's net income appears to be on an upward trend, with a most recent value of $309.09 million in 2026, falling from -$115.41 million in 2017. The previous period was $1.07 billion in 2025. See Docusign's forecast for analyst expectations on what's next for the company.

Docusign's total operating income in 2026 was $298.58 million, based on the following breakdown:

Total Gross Profit: $2.56 billion
Total Operating Expenses: $2.26 billion

Over the last 9 years, Docusign's total revenue changed from $381.46 million in 2017 to $3.22 billion in 2026, a change of 744.0%.

Docusign's total liabilities were at $2.31 billion at the end of 2026, a 15.0% increase from 2025, and a 462.3% increase since 2018.

In the past 8 years, Docusign's cash and equivalents has ranged from $241.20 million in 2020 to $797.06 million in 2024, and is currently $602.44 million as of their latest financial filing in 2026.

Over the last 9 years, Docusign's book value per share changed from 0.00 in 2017 to 9.58 in 2026, a change of 957.6%.

Related Companies

Financial statements for NASDAQ:DOCU last updated on 6/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Docusign (DOCU) Financials

Financials Breakdown Chart

Key Financial Trends

Docusign Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Docusign (DOCU) Financials

Annual Income Statements for Docusign

Quarterly Income Statements for Docusign

Annual Cash Flow Statements for Docusign

Quarterly Cash Flow Statements for Docusign

Annual Balance Sheets for Docusign

Quarterly Balance Sheets for Docusign

Annual Metrics And Ratios for Docusign

Quarterly Metrics And Ratios for Docusign

Financials Breakdown Chart

Key Financial Trends

Docusign Financials - Frequently Asked Questions

When does Docusign's fiscal year end?

How has Docusign's net income changed over the last 9 years?

What is Docusign's operating income?

How has Docusign's revenue changed over the last 9 years?

How much debt does Docusign have?

How much cash does Docusign have?

How has Docusign's book value per share changed over the last 9 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools